Who is sponsoring NCT01443338?

NCT01443338 is sponsored by Ministry of Health, China.

What condition does NCT01443338 study?

NCT01443338 studies Psoriasis Vulgaris.

What drugs are being tested in NCT01443338?

Interventions: Triptergium Wilfordii, Acitretin.

What is the status of NCT01443338?

NCT01443338 is currently UNKNOWN.

Last reviewed 2011-09-28 · How we verify

A Phase4,Multicenter, Randomized,Double-blind,Double Dummy, Parallel Controlled Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Treatment of Chinese Patients With Moderate to Severe Psoriasis Vulgaris

NCT01443338 Phase 4 UNKNOWN

The purpose of this study is to determine whether Triptergium wilfordii, and Acitretin are effective and safe in the treatment of patient of moderate to severe psoriasis vulgaris.

Details

Lead sponsor	Ministry of Health, China
Phase	Phase 4
Status	UNKNOWN
Enrolment	720
Start date	2011-09

Conditions

Psoriasis Vulgaris

Interventions

Triptergium Wilfordii
Acitretin

Primary outcomes

Change from baseline in plaque psoriasis as assessed by PASI(psoriasis area and severity index) response or PASI 75 (a patient that has an improvement from baseline PASI of at least 75%) — to 8 weeks treatment

Countries

China